In conclusion, in the CRC patients, raised serum VEGF and IL-6 may prove valuable non-invasive diagnostic indicators associated with advanced clinical stage and tumor metastasis that warrants further investigations. This evidence concerns the gene VEGFA and colorectal carcinoma.